Research Article

The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases

Table 2

Clinical and laboratory findings depending on heart failure occurrence.

HF present ()HF absent ()

eGFR (ml/min/1.732)76.1 ± 26.182.9 ± 22.60.09
Creatinine (mmol/l)90.0 ± 30.981.1 ± 48.50.01
ALT (IU/l)30.5 ± 21.431.2 ± 22.6ns
AST (IU/l)35.5 ± 34.227.1 ± 14.3ns
HGB (g/dl)13.5 ± 1.513.6 ± 1.5ns
HCT (%)41.3 ± 6.941.8 ± 6.0ns
RBC (106/ul)4.47 ± 0.64.46 ± 0.5ns
PLT (103/ul)203.8 ± 66.6210.0 ± 53.8ns
WBC (103/ul)7.5 ± 2.66.8 ± 2.2ns
25(OH)D (ng/ml)31.5 ± 8.9429.7 ± 10.2ns
Ca2+ (mmol/l)2.33 ± 0.132.37 ± 0.1ns
P (mmol/l)1.23 ± 0.171.18 ± 0.2ns
PTH (pg/ml)85.0 ± 52.664.5 ± 31.70.02

HF: heart failure; eGFR: estimated glomerular filtration rate; ALT: alanine aminotransferase; AST: aspartate aminotransferase; HGB: hemoglobin; HCT: hematocrit; RBC: red blood cells; PLT: platelets; WBC: white blood cells; 25(OH)D: 25-hydroxyvitamin D; Ca2+: total calcium; P: phosphorus; PTH: parathyroid hormone.